Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome

Journal of Neurotrauma

Volumn 19, Issue 5, 2002, Pages 653-666

  Takami, Toshihiro ^a   Oudega, Martin ^b   Bethea, John R ^b   Wood, Patrick M ^b   Kleitman, Naomi ^b   Bunge, Mary Bartlett ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Glucocorticosteroid; Inflammation; Methylprednisolone sodium succinate; Secondary tissue loss; Spinal cord injury

Indexed keywords

INTERLEUKIN 10; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CONTUSION; DRUG EFFECT; GRAY MATTER; MACROPHAGE ACTIVATION; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; OUTCOMES RESEARCH; RAT; RISK BENEFIT ANALYSIS; SPINAL CORD INJURY; THORACIC SPINE; TISSUE INJURY;

ANIMALS; DRUG THERAPY, COMBINATION; FEMALE; HINDLIMB; INTERLEUKIN-10; METHYLPREDNISOLONE; MOVEMENT; NERVE FIBERS; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 0036260491     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502753754118     Document Type: Article

References (66)

1. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury
2. Pathophysiology of spinal cord trauma
3. Lipid hydrolysis and peroxidation in injured spinal cord: Partial protection with methylprednisolone or vitamin E and selenium
4. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity
5. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels
6. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat
7. A sensitive and reliable locomotor rating scale for open field testing in rats
8. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection
9. Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673
10. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
11. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
12. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-Year follow-up data. Results of the second National Acute Spinal Cord Injury Study
13. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone
14. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism
15. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury
16. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
17. Schwann cell and olfactory ensheathing glia transplantation in the moderately contused adult rat thoracic spinal cord
18. Acute inflammatory response in spinal cord following impact injury
19. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord
20. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
21. Postischemic hypothermia and IL-10 treatment provide longlasting neuroprotection of CA1 hippocampus following transient global ischemia in rats
22. Megadose corticosteroid therapy following experimental traumatic spinal injury
23. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse
24. Failure of methylprednisolone to improve the outcome of spinal cord injuries
25. Consequences of high-dose steroid therapy for acute spinal cord injury
26. Microglial secretion products and their impact on the nervous system
27. Partial and complete deafferentation of cat hindlimb: The contribution of behavioral substitution to recovery of motor function
28. Spared-root deafferentation of a cat's hindlimb: Hierarchical regulation of pathways mediating recovery of motor behavior
29. A comparative study of steroid therapy in acute experimental spinal cord injury
30. A monitored contusion model of spinal cord injury in the rat
31. Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury
32. Effect of 4-aminopyridine and single-dose methyl-prednisolone on functional recovery after a chronic spinal cord injury
33. Glucocorticoid effects on central nervous excitability and synaptic transmission
34. The neuroprotective pharmacology of methylprednisolone
35. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis
36. The recovery of postural reflexes and locomotion following low thoracic hemisection in adult cats involves compensation by undamaged primary afferent pathways
37. Methylprednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood
38. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care
39. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury
40. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury
41. Microglia: A sensor for pathological events in the CNS
42. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia
43. Validation of the weight-drop contusion model in rats: A comparative study of human spinal cord injury
44. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials
45. Spinal cord contusion in the rat: Morphometric analyses of alterations in the spinal cord
46. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat
47. Long-term effects of methylprednisolone following transection of adult rat spinal cord
48. Regeneration of adult rat sensory axons into intraspinal nerve grafts: Promoting effects of conditioning lesion and graft predegeneration
49. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse
50. Effects of interleukin- 10 (IL- 10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat
51. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
52. Cyclosporin A treatment following spinal cord injury to the rat: Behavioral effects and seteological assessment of tissue sparing
53. Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats
54. Differences in the response to oxidative stress and mutant frequency in CD (Sprague-Dawley) and Fischer 344 rats due to an induced inflammatory response
55. Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats
56. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue
57. High-dose methylprednisolone in the management of acute spinal cord injury - A systematic review from a clinical perspective
58. Cytokines in CNS disorders: Neurotoxicity and neuroprotection
59. Role of leukocytes in spinal cord injury in rats
60. Update on the pathophysiology and pathology of acute spinal cord injury
61. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
62. Embryonic cord transplants in peripheral nerve restore skeletal muscle function
63. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1
64. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes
65. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainite antagonist NBQX
66. Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury